"Kyle's decades of financial, transactional and operational experience in our industry will make an immediate and positive ...

Zurich-based startup Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...

The biopharmaceutical industry saw a strong start to 2025, despite ongoing uncertainty around the potential impact of US ...

Investors often rely on the healthcare sector to safeguard their investments. This is because the demand for healthcare services does not vary too much with respect to market conditions and thus the ...

The Fed’s interest rate pause, closed capital markets, the tariff storm, and mass layoffs at the U.S. FDA create a ...

Here are two stocks with buy rank and strong value characteristics for investors to consider today, April 23: Phio ...

Private businesses that give away all profits and also succeed as businesses are scarce; the Newman’s Own food branding ...

LUND, SE / ACCESS Newswire / April 23, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announces that Shanghai Henlius Biotech, Inc. ("Henlius") has initiated a Phase 2 clinical trial with ...

Market turmoil may have frozen the traditional IPO pipeline, but German antibody biotech Veraxa is turning to the special ...

Let's see how the company performed during the three months. The post Telix shares rocket 15% on stellar Q1 sales update ...

We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are ...

Neurocrine Biosciences' valbenazine shows promise as an adjunctive therapy for Schizophrenia, with phase 3 data expected in ...